Toshihiro Fujita
Satsumasendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study.
Journal: Therapeutic advances in medical oncology
Published: June 26, 2025
Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer.
Journal: Frontiers in oncology
Published: May 11, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302).
Journal: Therapeutic advances in medical oncology
Published: November 21, 2024
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.
Journal: Oncology
Published: August 13, 2024
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Older Versus Younger Patients With Unresectable Pancreatic Cancer: The Multicenter NAPOLEON-2 Study.
Journal: Asia-Pacific journal of clinical oncology
Published: July 25, 2024
Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan.
Journal: Gastrointestinal endoscopy
Published: April 13, 2024
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
Journal: Scientific reports
Published: February 24, 2024
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.
Journal: Scientific reports
Published: November 14, 2023
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).
Journal: Scientific reports
Published: September 29, 2023
Comparison of recurrent biliary obstruction with the use of metal and plastic stents in EUS-guided biliary drainage: A propensity score-matched analysis.
Journal: Endoscopic ultrasound
Published: December 13, 2022
Efficacy and safety of a novel anti-reflux metal stent during neoadjuvant chemotherapy for pancreatic cancer: A prospective multicenter exploratory study.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: May 24, 2022
Last Updated: 09/26/2026